Search

Samuel A. Acquah

Examiner (ID: 20)

Most Active Art Unit
1711
Art Unit(s)
1207, 1754, 1503, 2899, 1711, 1774
Total Applications
2690
Issued Applications
2329
Pending Applications
91
Abandoned Applications
269

Applications

Application numberTitle of the applicationFiling DateStatus
19/110409 COMPOSITION AND METHOD FOR REMOVING PLAQUE FROM AN ARTERY Mar 9, 2025 Pending
Array ( [id] => 20059612 [patent_doc_number] => 20250197834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/071092 [patent_app_country] => US [patent_app_date] => 2025-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 140575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19071092 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/071092
PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF Mar 4, 2025 Pending
Array ( [id] => 20059615 [patent_doc_number] => 20250197837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/069321 [patent_app_country] => US [patent_app_date] => 2025-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19069321 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/069321
SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF Mar 3, 2025 Pending
Array ( [id] => 20121816 [patent_doc_number] => 20250236847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-24 [patent_title] => COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION [patent_app_type] => utility [patent_app_number] => 19/060404 [patent_app_country] => US [patent_app_date] => 2025-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19060404 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/060404
COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION Feb 20, 2025 Pending
Array ( [id] => 19877138 [patent_doc_number] => 20250109395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME [patent_app_type] => utility [patent_app_number] => 18/970552 [patent_app_country] => US [patent_app_date] => 2024-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18970552 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/970552
S. pyogenes CAS9 mutant genes and polypeptides encoded by same Dec 4, 2024 Issued
Array ( [id] => 20393473 [patent_doc_number] => 20250368948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => PRODUCT, SYSTEM AND METHOD OF CELL CULTIVATION [patent_app_type] => utility [patent_app_number] => 18/927171 [patent_app_country] => US [patent_app_date] => 2024-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 125322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927171 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/927171
PRODUCT, SYSTEM AND METHOD OF CELL CULTIVATION Oct 24, 2024 Pending
Array ( [id] => 19855764 [patent_doc_number] => 12258588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-25 [patent_title] => Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/919946 [patent_app_country] => US [patent_app_date] => 2024-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 9 [patent_no_of_words] => 13318 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919946 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/919946
Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof Oct 17, 2024 Issued
Array ( [id] => 19877133 [patent_doc_number] => 20250109390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => COMPOSITIONS FOR PREVENTING OR TREATING CORONAVIRUS INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/914016 [patent_app_country] => US [patent_app_date] => 2024-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68448 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18914016 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/914016
Compositions for preventing or treating coronavirus infections Oct 10, 2024 Issued
Array ( [id] => 19809737 [patent_doc_number] => 12241109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Host cells comprising a recombinant casein protein and a recombinant kinase protein [patent_app_type] => utility [patent_app_number] => 18/886925 [patent_app_country] => US [patent_app_date] => 2024-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 43 [patent_no_of_words] => 90167 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886925 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/886925
Host cells comprising a recombinant casein protein and a recombinant kinase protein Sep 15, 2024 Issued
Array ( [id] => 19682411 [patent_doc_number] => 20250000956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => RECOMBINANT CELL WALL HYDROLASES [patent_app_type] => utility [patent_app_number] => 18/882318 [patent_app_country] => US [patent_app_date] => 2024-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882318 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/882318
Recombinant cell wall hydrolases Sep 10, 2024 Issued
Array ( [id] => 20059650 [patent_doc_number] => 20250197872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => ALLULOSE EPIMERASE EXPRESSION CASSETTE AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/808665 [patent_app_country] => US [patent_app_date] => 2024-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 802 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18808665 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/808665
ALLULOSE EPIMERASE EXPRESSION CASSETTE AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME Aug 18, 2024 Pending
Array ( [id] => 19991125 [patent_doc_number] => 20250129347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES [patent_app_type] => utility [patent_app_number] => 18/798042 [patent_app_country] => US [patent_app_date] => 2024-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18798042 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/798042
ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES Aug 7, 2024 Pending
Array ( [id] => 19800825 [patent_doc_number] => 20250066750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity [patent_app_type] => utility [patent_app_number] => 18/795872 [patent_app_country] => US [patent_app_date] => 2024-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18795872 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/795872
Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity Aug 5, 2024 Pending
Array ( [id] => 20048343 [patent_doc_number] => 20250186565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/777129 [patent_app_country] => US [patent_app_date] => 2024-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777129 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/777129
CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS Jul 17, 2024 Pending
Array ( [id] => 19631460 [patent_doc_number] => 20240409909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => ALPHA-AMYLASE VARIANTS [patent_app_type] => utility [patent_app_number] => 18/774233 [patent_app_country] => US [patent_app_date] => 2024-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774233 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/774233
ALPHA-AMYLASE VARIANTS Jul 15, 2024 Pending
Array ( [id] => 20059649 [patent_doc_number] => 20250197871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => PROMOTER FOR CONSTITUTIVE EXPRESSION, TARGET PROTEIN EXPRESSION SYSTEM INCLUDING SAME, AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/772544 [patent_app_country] => US [patent_app_date] => 2024-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18772544 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/772544
PROMOTER FOR CONSTITUTIVE EXPRESSION, TARGET PROTEIN EXPRESSION SYSTEM INCLUDING SAME, AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME Jul 14, 2024 Pending
Array ( [id] => 19746032 [patent_doc_number] => 20250034597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci [patent_app_type] => utility [patent_app_number] => 18/764634 [patent_app_country] => US [patent_app_date] => 2024-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11128 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18764634 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/764634
RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci Jul 4, 2024 Pending
Array ( [id] => 19685445 [patent_doc_number] => 20250003990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS [patent_app_type] => utility [patent_app_number] => 18/761632 [patent_app_country] => US [patent_app_date] => 2024-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74912 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18761632 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/761632
ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS Jul 1, 2024 Pending
Array ( [id] => 19658803 [patent_doc_number] => 20240425868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => ENGINEERED PLASMODIA AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 18/752946 [patent_app_country] => US [patent_app_date] => 2024-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25440 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18752946 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/752946
ENGINEERED PLASMODIA AND RELATED METHODS Jun 24, 2024 Pending
Array ( [id] => 20007453 [patent_doc_number] => 20250145675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => PRODUCTION OF NATURAL PEPTIDE SWEETENER [patent_app_type] => utility [patent_app_number] => 18/745784 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745784 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/745784
PRODUCTION OF NATURAL PEPTIDE SWEETENER Jun 16, 2024 Pending
Menu